1-10 of 10
Eline Menu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 4110: Identification of tumor peptides for therapeutic mRNA vaccination in a mouse multiple myeloma model

Arne Van der Vreken, Fabien Thery, Sofie Meulewaeter, Karin Vanderkerken, Elke De Bruyne, Kim De Veirman, Lorenzo Franceschini, Rein Verbeke, Francis Impens, Ine Lentacker, Karine Breckpot, Eline Menu
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 4110.
https://doi.org/10.1158/1538-7445.AM2024-4110
Published: 22 March 2024
View article titled, Abstract 4110: Identification of tumor peptides for therapeutic mRNA vaccination in a mouse multiple myeloma model
Journal Articles

Abstract 4181: AXL-specific single domain antibodies show diagnostic potential and anti-tumor activity in acute myeloid leukemia

Niels Vandewalle, Hatice Satilmis, Emma M. Verheye, Rong Fan, Yanmeng Wang, Timo W. De Groof, Tessa Kerre, Nathan De Beule, Ann De Becker, Elke De Bruyne, Eline Menu, Karin Vanderkerken, Karine Breckpot, Nick Devoogdt, Kim De Veirman
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 4181.
https://doi.org/10.1158/1538-7445.AM2024-4181
Published: 22 March 2024
View article titled, Abstract 4181: AXL-specific single domain antibodies show diagnostic potential and anti-tumor activity in acute myeloid leukemia
Journal Articles

Hypoxic Bone Marrow Stromal Cells Secrete miR-140–5p and miR-28–3p That Target SPRED1 to Confer Drug Resistance in Multiple Myeloma

Hui Zhang, Zhimin Du, Chenggong Tu, Xinyan Zhou, Eline Menu, Jinheng Wang
Journal: Cancer Research
Cancer Res (2024) 84 (1): 39–55.
https://doi.org/10.1158/0008-5472.CAN-23-0189
Published: 02 January 2024
View article titled, Hypoxic Bone Marrow Stromal Cells Secrete miR-140–5p and miR-28–3p That Target SPRED1 to Confer Drug Resistance in Multiple Myeloma
Open the PDF for Hypoxic Bone Marrow Stromal Cells Secrete miR-140–5p and miR-28–3p That Target SPRED1 to Confer Drug Resistance in Multiple Myeloma in another window
Includes: Supplementary data
Journal Articles

Abstract 2505: PYCR1 inhibition in multiple myeloma-associated stroma limits tumor growth

Inge Oudaert, Catharina Muylaert, Hatice Satilmis, Sylvia Faict, Kim De Veirman, Elke De Bruyne, Karin Vanderkerken, Eline Menu
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 2505.
https://doi.org/10.1158/1538-7445.AM2023-2505
Published: 04 April 2023
View article titled, Abstract 2505: PYCR1 inhibition in multiple myeloma-associated stroma limits tumor growth
Journal Articles

Abstract LB-117: Role of ectoenzymes CD39 and CD73 in the immune response to multiple myeloma

Rui Yang, Samah Elsaadi, Kristine Misund, Geir Slupphaug, Eline Menu, Carl Hay, Zac Cooper, Karin Vanderkerken, Magne Børset, Anne Marit Sponaas
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): LB-117.
https://doi.org/10.1158/1538-7445.AM2018-LB-117
Published: 01 July 2018
View article titled, Abstract LB-117: Role of ectoenzymes CD39 and CD73 in the immune response to multiple myeloma
Journal Articles

Abstract 2120: Inhibition of multiple myeloma exosomes prevents bone loss and reduces tumor growth

Sylvia T. Faict, Kim De Veirman, Ken Maes, Elke De Bruyne, Roy Heusschen, Jo Caers, Karin Vanderkerken, Rik Schots, Eline Menu
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 2120.
https://doi.org/10.1158/1538-7445.AM2018-2120
Published: 01 July 2018
View article titled, Abstract 2120: Inhibition of multiple myeloma exosomes prevents bone loss and reduces tumor growth
Journal Articles

Loss of RASSF4 Expression in Multiple Myeloma Promotes RAS-Driven Malignant Progression

Eva De Smedt, Ken Maes, Stefaan Verhulst, Hui Lui, Alboukadel Kassambara, Anke Maes, Nicolas Robert, Carlo Heirman, Andrew Cakana, Dirk Hose, Karine Breckpot, Leo A. van Grunsven, Kim De Veirman, Eline Menu, Karin Vanderkerken, Jérôme Moreaux, Elke De Bruyne
Journal: Cancer Research
Cancer Res (2018) 78 (5): 1155–1168.
https://doi.org/10.1158/0008-5472.CAN-17-1544
Published: 28 February 2018
View article titled, Loss of RASSF4 Expression in Multiple Myeloma Promotes RAS-Driven Malignant Progression
Open the PDF for Loss of RASSF4 Expression in Multiple Myeloma Promotes RAS-Driven Malignant Progression in another window
Includes: Supplementary data
Journal Articles

Bortezomib Alone or in Combination with the Histone Deacetylase Inhibitor JNJ-26481585: Effect on Myeloma Bone Disease in the 5T2MM Murine Model of Myeloma

Sarah Deleu, Miguel Lemaire, Janine Arts, Eline Menu, Els Van Valckenborgh, Isabelle Vande Broek, Hendrik De Raeve, Les Coulton, Ben Van Camp, Peter Croucher, Karin Vanderkerken
Journal: Cancer Research
Cancer Res (2009) 69 (13): 5307–5311.
https://doi.org/10.1158/0008-5472.CAN-08-4472
Published: 01 July 2009
View article titled, Bortezomib Alone or in Combination with the Histone Deacetylase Inhibitor JNJ-26481585: Effect on Myeloma Bone Disease in the 5T2MM Murine Model of Myeloma
Open the PDF for Bortezomib Alone or in Combination with the Histone Deacetylase Inhibitor JNJ-26481585: Effect on Myeloma Bone Disease in the 5T2MM Murine Model of Myeloma in another window
Journal Articles

A Novel Therapeutic Combination Using PD 0332991 and Bortezomib: Study in the 5T33MM Myeloma Model

Eline Menu, Josefina Garcia, Xiangao Huang, Maurizio Di Liberto, Peter L. Toogood, Isan Chen, Karin Vanderkerken, Selina Chen-Kiang
Journal: Cancer Research
Cancer Res (2008) 68 (14): 5519–5523.
https://doi.org/10.1158/0008-5472.CAN-07-6404
Published: 15 July 2008
View article titled, A Novel Therapeutic Combination Using PD 0332991 and Bortezomib: Study in the 5T33MM Myeloma Model
Open the PDF for A Novel Therapeutic Combination Using PD 0332991 and Bortezomib: Study in the 5T33MM Myeloma Model in another window
Journal Articles

Inhibition of p38α Mitogen-Activated Protein Kinase Prevents the Development of Osteolytic Bone Disease, Reduces Tumor Burden, and Increases Survival in Murine Models of Multiple Myeloma

Karin Vanderkerken, Satya Medicherla, Les Coulton, Hendrik De Raeve, Angelo Willems, Michelle Lawson, Ben Van Camp, Andrew A. Protter, Linda S. Higgins, Eline Menu, Peter I. Croucher
Journal: Cancer Research
Cancer Res (2007) 67 (10): 4572–4577.
https://doi.org/10.1158/0008-5472.CAN-06-4361
Published: 17 May 2007
View article titled, Inhibition of p38α Mitogen-Activated Protein Kinase Prevents the Development of Osteolytic Bone Disease, Reduces Tumor Burden, and Increases Survival in Murine Models of Multiple Myeloma
Open the PDF for Inhibition of p38α Mitogen-Activated Protein Kinase Prevents the Development of Osteolytic Bone Disease, Reduces Tumor Burden, and Increases Survival in Murine Models of Multiple Myeloma in another window